
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4658120
[patent_doc_number] => 20080026982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Mutant APOBEC3G molecules for inhibiting replication of HIV'
[patent_app_type] => utility
[patent_app_number] => 11/489692
[patent_app_country] => US
[patent_app_date] => 2006-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14302
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11489692
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/489692 | Mutant APOBEC3G molecules for inhibiting replication of HIV | Jul 18, 2006 | Abandoned |
Array
(
[id] => 5079205
[patent_doc_number] => 20070122429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Designed antigens to elicit neutralizing antibodies against sterically restricted antigen and method of using same'
[patent_app_type] => utility
[patent_app_number] => 11/484101
[patent_app_country] => US
[patent_app_date] => 2006-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14780
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122429.pdf
[firstpage_image] =>[orig_patent_app_number] => 11484101
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/484101 | Designed antigens to elicit neutralizing antibodies against sterically restricted antigen and method of using same | Jul 10, 2006 | Abandoned |
Array
(
[id] => 5563693
[patent_doc_number] => 20090136545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'PORCINE ROTAVIRUS REASSORTANT COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/994645
[patent_app_country] => US
[patent_app_date] => 2006-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9256
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136545.pdf
[firstpage_image] =>[orig_patent_app_number] => 11994645
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/994645 | PORCINE ROTAVIRUS REASSORTANT COMPOSITIONS | Jul 9, 2006 | Abandoned |
Array
(
[id] => 6530507
[patent_doc_number] => 20100221241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'CONSTRAINED HIV ENVELOPE-BASED IMMUNOGEN THAT SIMULTANEOUSLY PRESENTS RECEPTOR AND CORECEPTOR BINDING SITES'
[patent_app_type] => utility
[patent_app_number] => 11/994870
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8683
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11994870
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/994870 | CONSTRAINED HIV ENVELOPE-BASED IMMUNOGEN THAT SIMULTANEOUSLY PRESENTS RECEPTOR AND CORECEPTOR BINDING SITES | Jul 5, 2006 | Abandoned |
Array
(
[id] => 221142
[patent_doc_number] => 07608688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'HIV-1 protein associated with broadly reactive neutralizing antibody response'
[patent_app_type] => utility
[patent_app_number] => 11/473036
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 13868
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608688.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473036
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473036 | HIV-1 protein associated with broadly reactive neutralizing antibody response | Jun 22, 2006 | Issued |
Array
(
[id] => 6314476
[patent_doc_number] => 20100111995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Antigen conjugates and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/922217
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27449
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111995.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922217 | Antigen conjugates and uses thereof | Jun 13, 2006 | Abandoned |
Array
(
[id] => 5533535
[patent_doc_number] => 20090233323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'METHOD FOR ANALYSIS OF NKT CELL FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 11/917817
[patent_app_country] => US
[patent_app_date] => 2006-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7973
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917817 | METHOD FOR ANALYSIS OF NKT CELL FUNCTION | Jun 8, 2006 | Abandoned |
Array
(
[id] => 5753515
[patent_doc_number] => 20060222664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production'
[patent_app_type] => utility
[patent_app_number] => 11/449303
[patent_app_country] => US
[patent_app_date] => 2006-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 24601
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20060222664.pdf
[firstpage_image] =>[orig_patent_app_number] => 11449303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/449303 | Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production | Jun 7, 2006 | Abandoned |
Array
(
[id] => 5539134
[patent_doc_number] => 20090220939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Methods for determing resistance or susceptibility to hi entry inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/921751
[patent_app_country] => US
[patent_app_date] => 2006-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 25116
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220939.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921751 | Methods for determining resistance or susceptibility to HIV entry inhibitors | Jun 5, 2006 | Issued |
Array
(
[id] => 887210
[patent_doc_number] => 07348011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-25
[patent_title] => 'Hepatitis C virus vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/447049
[patent_app_country] => US
[patent_app_date] => 2006-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 27
[patent_no_of_words] => 13077
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/348/07348011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11447049
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/447049 | Hepatitis C virus vaccine | Jun 5, 2006 | Issued |
Array
(
[id] => 4758856
[patent_doc_number] => 20080311082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Process for Treating Animal Waste'
[patent_app_type] => utility
[patent_app_number] => 11/915281
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9056
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311082.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915281
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915281 | Process for Treating Animal Waste | May 25, 2006 | Abandoned |
Array
(
[id] => 5182945
[patent_doc_number] => 20070054292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Bacteriophage linked immunosorbent assay for rapid, sensitive detection of multiple analytes'
[patent_app_type] => utility
[patent_app_number] => 11/438982
[patent_app_country] => US
[patent_app_date] => 2006-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3156
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054292.pdf
[firstpage_image] =>[orig_patent_app_number] => 11438982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/438982 | Bacteriophage linked immunosorbent assay for rapid, sensitive detection of multiple analytes | May 22, 2006 | Issued |
Array
(
[id] => 5028006
[patent_doc_number] => 20070269453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Highly expressed peptide of white spot syndrome virus in hosts and application thereof'
[patent_app_type] => utility
[patent_app_number] => 11/438235
[patent_app_country] => US
[patent_app_date] => 2006-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4132
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11438235
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/438235 | Highly expressed peptide of white spot syndrome virus in hosts and application thereof | May 21, 2006 | Issued |
Array
(
[id] => 5661043
[patent_doc_number] => 20060251639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Compositions and methods for treating HIV infection with cupredoxin and cytochrame C'
[patent_app_type] => utility
[patent_app_number] => 11/436591
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18897
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251639.pdf
[firstpage_image] =>[orig_patent_app_number] => 11436591
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436591 | Compositions and methods for treating HIV infection with cupredoxin and cytochrome c | May 18, 2006 | Issued |
Array
(
[id] => 917631
[patent_doc_number] => 07323557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-29
[patent_title] => 'Genome of the HIV-1 inter-subtype (C/B\') and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/438134
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 26
[patent_no_of_words] => 11699
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/323/07323557.pdf
[firstpage_image] =>[orig_patent_app_number] => 11438134
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/438134 | Genome of the HIV-1 inter-subtype (C/B') and use thereof | May 18, 2006 | Issued |
Array
(
[id] => 5502721
[patent_doc_number] => 20090163409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Trappin-2 (elafin) inhibits HIV'
[patent_app_type] => utility
[patent_app_number] => 11/914392
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6698
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914392 | Trappin-2 (elafin) inhibits HIV | May 15, 2006 | Abandoned |
Array
(
[id] => 4663144
[patent_doc_number] => 20080254051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Use of Native Peptides and Their Optimized Derivatives For Vaccination'
[patent_app_type] => utility
[patent_app_number] => 11/913138
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8975
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254051.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913138
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913138 | Use of native peptides and their optimized derivatives for vaccination | May 8, 2006 | Issued |
Array
(
[id] => 4949893
[patent_doc_number] => 20080306019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Dopamine Receptor Agonists in the Treatment and Prevention of Hiv-Induced Dementia'
[patent_app_type] => utility
[patent_app_number] => 11/913519
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 49204
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306019.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913519
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913519 | Dopamine Receptor Agonists in the Treatment and Prevention of Hiv-Induced Dementia | May 2, 2006 | Abandoned |
Array
(
[id] => 5034737
[patent_doc_number] => 20070099276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Retrovirus-like particles and retroviral vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/413614
[patent_app_country] => US
[patent_app_date] => 2006-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13794
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099276.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413614
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413614 | Retrovirus-like particles and retroviral vaccines | Apr 26, 2006 | Abandoned |
Array
(
[id] => 281932
[patent_doc_number] => 07553932
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-06-30
[patent_title] => 'Methods of treating viral infection with IL-10 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/411222
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27312
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553932.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411222
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411222 | Methods of treating viral infection with IL-10 receptor antagonists | Apr 24, 2006 | Issued |